Inbrija Will Be an Inhaled "On Demand" Med for Parkinson's Disease
Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.
Think of Inbrija as a fast-acting "on demand" levodopa. It starts to work in about 10 minutes...and lasts about an hour.
Inbrija won't replace daily meds. Instead, it'll be used as needed to treat "off" episodes...when scheduled carbidopa/levodopa (Sinemet, etc) wears off between doses and symptoms (rigidity, tremor, etc) return.